L
Laura C. Coates
Researcher at University of Oxford
Publications - 371
Citations - 11537
Laura C. Coates is an academic researcher from University of Oxford. The author has contributed to research in topics: Psoriatic arthritis & Medicine. The author has an hindex of 49, co-authored 290 publications receiving 9291 citations. Previous affiliations of Laura C. Coates include Fox Chase Cancer Center & National Institute for Health Research.
Papers
More filters
Journal ArticleDOI
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis
Laura C. Coates,Arthur Kavanaugh,Philip J. Mease,Enrique R. Soriano,Maria Laura Acosta-Felquer,April W. Armstrong,Wilson Bautista-Molano,Wolf-Henning Boehncke,Willemina Campbell,Alberto Cauli,Luis R. Espinoza,Oliver FitzGerald,Dafna D. Gladman,Alice B. Gottlieb,Philip S. Helliwell,M. Elaine Husni,Thorvardur Jon Love,Ennio Lubrano,Neil McHugh,Peter Nash,Alexis Ogdie,Ana Maria Orbai,Andrew Parkinson,Denis O'Sullivan,Cheryl F. Rosen,Sergio Schwartzman,Evan L. Siegel,Sergio Toloza,William Tuong,Christopher T. Ritchlin +29 more
TL;DR: To update the 2009 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting patients with psoriatic arthritis (PsA).
Journal ArticleDOI
Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment
TL;DR: This study provides the first definition of a “state” of MDA in PsA and defines a target for treatment, which must now be validated in other populations and tested in clinical trials.
Journal ArticleDOI
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
Josef S. Smolen,Monika Schöls,Jürgen Braun,Maxime Dougados,Oliver FitzGerald,Dafna D. Gladman,Arthur Kavanaugh,Robert Landewé,Philip J. Mease,Joachim Sieper,Tanja Stamm,Maarten de Wit,Daniel Aletaha,Xenofon Baraliakos,Neil Betteridge,Filip Van den Bosch,Laura C. Coates,Paul Emery,Lianne S. Gensler,Laure Gossec,Philip S. Helliwell,Merryn Jongkees,Tore K Kvien,Robert D. Inman,Iain B. McInnes,Mara Maccarone,Pedro Machado,Anna Molto,Alexis Ogdie,Denis Poddubnyy,Christopher T. Ritchlin,Martin Rudwaleit,Adrian Tanew,Bing Thio,Douglas J. Veale,Kurt de Vlam,Désirée van der Heijde +36 more
TL;DR: There was broad agreement, now better supported by data than in 2012, that remission/inactive disease and, alternatively, low/minimal disease activity are the principal targets for the treatment of PsA.
Journal ArticleDOI
Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial
Laura C. Coates,Anna R. Moverley,Lucy McParland,Sarah Brown,Nuria Navarro-Coy,John O’Dwyer,David M. Meads,Paul Emery,Philip G. Conaghan,Philip S. Helliwell +9 more
TL;DR: Tight control of psoriatic arthritis disease activity through a treat-to-target approach significantly improves joint outcomes for newly diagnosed patients, with no unexpected serious adverse events reported.
Journal ArticleDOI
Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years
Alexander N. Bennett,Dennis McGonagle,Philip O'Connor,Elizabeth M A Hensor,Francisca Sivera,Laura C. Coates,Paul Emery,Helena Marzo-Ortega +7 more
TL;DR: In patients with early IBP, a combination of severe sacroiliitis and HLA-B27 positivity has a high specificity for development of ankylosing spondylitis, compared with mild or no sacroiliaitis, regardless of HLA -B27 status, which confers a low likelihood of developing AS.